A number of human neurodegenerative diseases such as Huntington's, Parkinson's, and ALS, are characterized by protein aggregates and often associated with aging. The biochemical consequence of misfolded or mutant proteins that self-associate to form protein aggregates should, in principle, be independent of cell type. However, the Huntingtin's gene, for example, is expressed widely in the body, yet protein aggregates and cell death are restricted to specific subsets of neuronal cells. The expression of polyglutamine (polyQ or CAG) expansions, as occurs in Huntington's, results in the appearance of size-dependent protein aggregates in yeast, Drosophila, and Caenorhabditis elegans , thus providing alternate model systems for genetic, biochemical, and cell biological investigations. Of these, C. elegans is a particularly interesting model, as subsets of the 302 neurons in the adult hermaphrodite can be differentially targeted to express aggregation-prone proteins. We have already shown that the expression of polyQ-containing proteins in C. elegans body wall muscle cells causes the size-dependent appearance of protein aggregates. The transition to aggregate formation expansions occurs at approximately 40 polyQ repeats. To investigate the sensitivity of neurons to polyQ induced aggregation, we have made constructs containing polyQ-YFP (Q0, 19, 40, and 82) under the control of the pan-neuronal
unc-119 promoter for the generation of transgenic animals. Our preliminary data reveals that Q19-YFP expressing animals exhibit a number of deficiencies including an egg laying defect and uncoordinated phenotype. In contrast, animals expressing Q40-YFP yield transgenic animals with low viability while no progeny expressing Q82-YFP were obtained. Future analysis will take advantage of the both forward and reverse genetics to screen for genes involved in the pan-neuronal, polyQ-induced phenotypes. We will also examine the role of neuronal sub-groups such as sensory or dopaminergic neurons, by generating constructs with subset-specific promoters expressing a series of polyQ-YFPs. This will enable us to determine whether neuronal subsets have differential susceptibility to polyQ induced protein aggregation. The use of subset-specific neuronal promoters will also provide a mechanism for investigating whether polyQ-induced phenotypes differ depending on the neuronal sub-group expressing polyQ.